During the past decade, West Houston Dermatology, PA conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Houston Dermatology, PA" #1 sponsor was "Astellas Pharma Inc" with 1 trials, followed by "Genentech, Inc." with 1 trials sponsored, "Janssen Scientific Affairs, LLC" with 1 trials sponsored, "LEO Pharma" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "West Houston Dermatology, PA" are "Psoriasis" (3 trials), "Atopic Dermatitis" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "West Houston Dermatology, PA" in a lesser frequency.

Most popular intervention types in "West Houston Dermatology, PA" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alefacept exposure" (1 trials), "PF-04965842 100 mg" (1 trials), "PF-04965842 200 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "West Houston Dermatology, PA" are 5 trials for "All" genders.

Currently, there are NaN active trials in "West Houston Dermatology, PA". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in West Houston Dermatology, PA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in West Houston Dermatology, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".